Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01032-2Source: DataRank Database

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia is a research paper published in Journal of Hematology & Oncology (2021). On theSindex it has a DataRank of 0.601. It has been cited 54 times.

N/A

0.601DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)Impact (FWCI 3.04)OA: goldTopics (98)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.601

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (27)

Zachary A. Hing,Bonnie K. Harrington ORCID,J.M. Baumhardt,Hatice Gülçin Özer ORCID,Amy Lehman

Live enrichment

PubMed:33451349 PMC:PMC7809770 OpenAlex:https://openalex.org/W3120455747

National Institutes of Health

Grant: NIGMS T32 GM068412

National Institutes of Health

Grant: 5P30 CA016058

National Institutes of Health

Grant: 5R01 CA223165

National Institutes of Health

Grant: R35 CA197734

National Institutes of Health

Grant: P30 CA016058

National Cancer Institute

Grant: P01 5P01CA081534

National Cancer Institute

Grant: R01 CA182905-01

National Cancer Institute

Grant: R35 CA198183

Cancer Prevention and Research Institute of Texas

Grant: RP180410

Cancer Prevention and Research Institute of Texas

Grant: RP170170

NCI NIH HHS

Grant: R01 CA214046

NIGMS NIH HHS

Grant: T32 GM068412

NCI NIH HHS

Grant: R01 CA240493

NIGMS NIH HHS

Grant: P41 GM109824

NCI NIH HHS

Grant: R01 CA223165

NIGMS NIH HHS

Grant: R01 GM069909

NCI NIH HHS

Grant: R01 CA182905

NCI NIH HHS

Grant: F30 CA196082

NCI NIH HHS

Grant: P01 CA081534

NCI NIH HHS

Grant: R01 CA192928

National Institutes of Health

Grant: 5R35CA197734-06

Targeted Therapy for Leukemia

National Institutes of Health

Grant: 5T32GM068412-13

Integrative training in biomedical systems

National Institutes of Health

Grant: 5R01CA182905-03

Protein-coding and non-coding RNA biomarkers for early detection of CLL

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

National Institutes of Health

Grant: 5R01CA223165-04

Targeting NAMPT in Acute Myeloid Leukemia

National Institutes of Health

Grant: 5P01CA081534-09

Immune Tolerance of CLL Antigens

FWCI

3.04

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-021-01032-2

publisherhttps://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-021-01032-2

publisherhttp://link.springer.com/content/pdf/10.1186/s13045-021-01032-2.pdf

publisherhttp://link.springer.com/article/10.1186/s13045-021-01032-2/fulltext.html

journalhttps://doi.org/10.1186/s13045-021-01032-2

Fields of Study

Nuclear Structure and FunctionChronic Lymphocytic Leukemia ResearchAmyloidosis: Diagnosis, Treatment, Outcomes0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsEpigenesis, GeneticFemaleGene Expression Regulation, LeukemicHumansKaryopherinsLeukemia, Lymphocytic, Chronic, B-CellMaleMice, Inbred C57BLModels, MolecularMutationReceptors, Cytoplasmic and NuclearRetrospective StudiesTranscriptomeExportin 1 ProteinMice

MeSH Terms

Exportin 1 ProteinAnimalsFemaleHumansMaleMice, Inbred C57BLModels, MolecularMutationRetrospective StudiesLeukemia, Lymphocytic, Chronic, B-CellGene Expression Regulation, LeukemicReceptors, Cytoplasmic and NuclearKaryopherinsEpigenesis, GeneticMiceTranscriptome

Keywords

Chronic lymphocytic leukemiaBiologyMutationEpigeneticsCancer researchLeukemiaNonsynonymous substitutionGeneticsGeneGenomeExpression ProfilingMutation AnalysisMouse ModelSinesXpo1SelinexorMaleModels, MolecularLymphomaCytoplasmic and NuclearReceptors, Cytoplasmic and NuclearExportin 1 ProteinCardiorespiratory Medicine and HaematologyInbred C57BLEpigenesis, GeneticMiceModelsReceptors2.1 Biological and endogenous factorsChronicRC254-282CancerLeukemicGene Expression Regulation, LeukemicNeoplasms. Tumors. Oncology. Including cancer and carcinogensHematologyLymphocyticFemale570Lymphatic ResearchOncology and Carcinogenesis610KaryopherinsCardiovascular medicine and haematologyRare DiseasesGeneticAnimalsHumansDiseases of the blood and blood-forming organsRetrospective StudiesBiomedical and Clinical SciencesResearchB-CellMolecularLeukemia, Lymphocytic, Chronic, B-CellMice, Inbred C57BLGene Expression RegulationRC633-647.5TranscriptomeEpigenesis

Sustainable Development Goals

SDG 3: 3. Good health